Cambridge Investment Research Advisors
GMED icon

Cambridge Investment Research Advisors’s Globus Medical GMED Stock Holding History

Cambridge Investment Research Advisors’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.39M Buy
17,596
+15,007
+580% +$1.28M ﹤0.01% 1844
2026
Q1 		$223K Buy
2,589
+26
+1% +$2.33K ﹤0.01% 3581
2025
Q4 		$224K Sell
2,563
-1,635
-39% -$124K ﹤0.01% 3483
2025
Q3 		$240K Buy
4,198
+288
+7% +$16.6K ﹤0.01% 3331
2025
Q2 		$231K Buy
3,910
+140
+4% +$9.04K ﹤0.01% 3210
2025
Q1 		$276K Buy
3,770
+428
+13% +$35.4K ﹤0.01% 2931
2024
Q4 		$276K Buy
+3,342
New +$264K ﹤0.01% 2898

Other funds holding GMED

BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
PM
Pembroke Management Montreal, Quebec, Canada $637M AUM 40.98% 1-Year Est. Return
AAS
Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
TB
Terril Brothers St. Louis, Missouri $388M AUM 29.38% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

Cambridge Investment Research Advisors's GMED Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Globus Medical (GMED) stake by 580% in Q2 2026, buying an estimated $1.28M and bringing the position to 17,596 shares worth $1.39M. The position accounts for ﹤0.01% of the portfolio, ranked #1844.

Cambridge Investment Research Advisors first reported a position in GMED in Q4 2024 and has held it in 7 quarters since. 161 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Cambridge Investment Research Advisors held 17,596 shares of Globus Medical worth $1.39M as of Q2 2026.
  • Cambridge Investment Research Advisors bought 15,007 Globus Medical shares in Q2 2026, an estimated $1.28M.
  • Globus Medical made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #1844 holding.
  • Cambridge Investment Research Advisors first reported a position in Globus Medical in Q4 2024 and has held it in 7 quarters since.
  • 161 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.